Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Synaptic focuses on dihydropyrimidinones for BPH

Sep. 29, 1997

Sildenafil continues to demonstrate efficacy in treating ED

Sep. 26, 1997

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Sep. 26, 1997

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Sep. 18, 1997

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...